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NK cells are innate lymphocytes with important roles in the 
defense against intracellular pathogens and in cancer immu-
nosurveillance. They have the capacity to recognize and kill 
target cells through a limited set of surface receptors and 
through the release of cytotoxic granules containing perfo-
rin and granzymes. NK cell development occurs mainly in 
the BM. After commitment to the NK cell lineage, NK cells 
undergo a maturation program (Huntington et al., 2007b). 
Three maturation intermediates can be defined on the basis 
of surface expression of CD27 and CD11b: CD11b−CD27+ 
NK cells (hereafter referred to as CD11b−, the most imma-
ture stage), CD11b+CD27+ (double positive [DP]), and CD-
11b+CD27− (CD27−, the most mature subset), respectively 
(Kim et al., 2002; Hayakawa and Smyth, 2006). During mat-
uration, NK cells progressively lose their capacity to pro-
liferate, acquire the full set of NK cell receptors as well as 
cytotoxic arsenal, and modify their trafficking machinery. 
In particular, they acquire sphingosine-1 phosphate recep-
tor 5 (S1PR5), which allows their egress from the BM and 
LNs and their circulation through the blood (Walzer et al., 
2007; Mayol et al., 2011).
Natural killer (NK) cell maturation is a tightly controlled process that endows NK cells with functional competence and the 
capacity to recognize target cells. Here, we found that the transcription factor (TF) Zeb2 was the most highly induced TF 
during NK cell maturation. Zeb2 is known to control epithelial to mesenchymal transition, but its role in immune cells is mostly 
undefined. Targeted deletion of Zeb2 resulted in impaired NK cell maturation, survival, and exit from the bone marrow. NK cell 
function was preserved, but mice lacking Zeb2 in NK cells were more susceptible to B16 melanoma lung metastases. Recipro-
cally, ectopic expression of Zeb2 resulted in a higher frequency of mature NK cells in all organs. Moreover, the immature 
phenotype of Zeb2−/− NK cells closely resembled that of Tbx21−/− NK cells. This was caused by both a dependence of Zeb2 
expression on T-bet and a probable cooperation of these factors in gene regulation. Transgenic expression of Zeb2 in Tbx21−/− 
NK cells partially restored a normal maturation, establishing that timely induction of Zeb2 by T-bet is an essential event during 
NK cell differentiation. Finally, this novel transcriptional cascade could also operate in human as T-bet and Zeb2 are similarly 
regulated in mouse and human NK cells.
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Several transcription factors (TFs) regulate NK cell mat-
uration. The T-box family member Eomesodermin (Eomes) is 
essential for the early transition from CD11b− to the DP stage 
(Gordon et al., 2012). Another T-box family member, T-bet, 
drives terminal NK cell maturation by reducing prolifera-
tion (Townsend et al., 2004), up-regulating the expression of 
S1pr5 mRNA (Jenne et al., 2009), and driving the transition 
to the CD27− mature stage (Soderquest et al., 2011). Here, 
in an effort to identify novel TFs involved in NK cell mat-
uration, we screened microarray data for genes up-regulated 
in mature NK cells and selected Zeb2 (zinc finger E-box–
binding protein 2) as a putative regulator of maturation. Zeb2 
and Zeb1 are TFs that share a similar protein domain orga-
nization and are known as master regulators of epithelial to 
mesenchymal transition (EMT; Comijn et al., 2001). EMT 
is a cellular program relevant to embryogenesis whereby ep-
ithelial cells are converted into mesenchymal cells (Thiery 
et al., 2009). Specific inactivation of Zeb2 in embryonic he-
matopoietic stem cells abrogates early hematopoietic lineage 
differentiation and affects cellular mobilization (Goossens et 
al., 2011). However, the in vivo role of Zeb2 in mature cells of 
the immune system remains unknown. Using conditional KO 
as well as overexpression mouse models, we show that Zeb2 
is essential to promote terminal NK cell maturation and that 
it functions downstream of T-bet.
RES ULTS AND DIS CUSSI ON
Zeb2 is essential for NK cell maturation
To identify novel genes controlling NK cell maturation, we 
screened microarray data (Chiossone et al., 2009) for TFs 
with a higher mRNA expression level in mature CD27− NK 
cells than in immature CD11b− NK cells. As shown in Fig. 
S1, the TF that best met this criterion was Zeb2. RT–quan-
titative PCR (qPCR) analysis of Zeb2 mRNA in NK cell 
maturation stages further corroborated this point (Fig. 1 A). 
Zeb2 expression was significantly higher in each of these sub-
sets than in other mature lymphocyte subsets (Fig. 1 A). Next, 
we measured ZEB2 transcript levels during human NK cell 
maturation. For this purpose, NK cell maturation interme-
diates were defined as shown in Fig.  1 B: CD56brightCD3− 
(stage I), CD56dimCD3−NKG2A+KIR−CD57− (stage II), 
NKG2A+KIR+CD57− (stage III), and NKG2A−KIR+CD57+ 
(stage IV; Björkström et al., 2010). Fig. 1 C shows that human 
ZEB2 mRNA expression was significantly up-regulated in 
the most mature stages, thus reflecting the mouse NK cell 
data. ZEB2 expression in human NK cells was linked to that 
of T-BET, a TF known to regulate late NK cell maturation.
To understand the role of Zeb2 in NK cells, we gener-
ated two complementary mouse models. We bred Ncr1iCre/+ 
mice (Narni-Mancinelli et al., 2011) with Zeb2fl/fl mice (Hi-
gashi et al., 2002) or with R26-Zeb2Tg/Tg mice (Tatari et al., 
2014). These genetic modifications allow selective inactiva-
tion of Zeb2 or transgenic (Tg) Zeb2 expression from the 
Rosa26 promoter in NK cells, respectively. As the Rosa26 
promoter is only moderately active, the total (endogenous 
+ transgene) levels of Zeb2 are significantly up-regulated 
in CD11b− and DP NK cells (Fig. 1 D) but not in mature 
CD27− NK cells, which express much higher levels of endog-
enous Zeb2. We first compared the distribution of NK cells 
in NK-Zeb2Tg/Tg, NK-Zeb2Tg/+, NK-Zeb2+/+, NK-Zeb2+/−, 
and NK-Zeb2−/− mice (as defined in Fig. S1 B). The loss of 
one or two Zeb2 alleles dramatically skewed the normal dis-
tribution of NK cells. Zeb2−/− NK cells tended to accumu-
late in the BM and were significantly decreased in the blood 
and in peripheral organs such as liver, lung, spleen, LNs, and 
salivary glands relative to control NK cells (Fig. 1, E and F; 
and not depicted). Zeb2-overexpressing mice had decreased 
NK cell numbers in the BM, whereas total splenic NK cell 
numbers were normal (Fig. 1, E and F). Analysis of CD11b 
and CD27 expression revealed that NK-Zeb2−/− mice vir-
tually lacked mature CD27− NK cells in all organs, whereas 
NK-Zeb2+/− mice had a milder but still profound phenotype 
(Fig. 1, G and H; and not depicted). Reciprocally, expression 
of one or two copies of the R26-based Zeb2 transgene re-
sulted in increased frequencies of mature CD27− NK cells in 
the spleen and in the BM, with a similar gene dosage effect 
(Fig. 1, G and H). The numbers of mature CD27− NK cells 
tended to increase in the spleen and BM of NK-Zeb2Tg/+ 
and NK-Zeb2Tg/Tg mice, and the numbers of immature 
CD11b− and DP NK cells were reduced, showing that Zeb2 
Tg expression promoted NK cell maturation (Fig.  1  I and 
not depicted). To further monitor NK cell maturation in the 
various mouse models, we also measured the expression of 
CD146 and KLRG1. KLRG1 and CD146 have previously 
been shown to associate with terminal NK cell maturation 
(Huntington et al., 2007a; Despoix et al., 2008). This analy-
sis further confirmed that the frequency of mature NK cells 
(CD11b+KLRG1+ and CD11b+CD146+) was proportional 
to the amount of Zeb2 expressed (Fig. 1 J).
Zeb2 is essential for the egress from BM and for the 
survival of mature NK cells
We next investigated whether the absence of CD27− NK cells 
in the periphery of NK-Zeb2−/− mice was associated with di-
minished survival, decreased exit from the BM, or both. First, 
we measured the ex vivo viability of NK cells in the spleen using 
Annexin V/dead cell staining. We found that mature Zeb2−/− 
NK cells displayed a decreased viability compared with control 
and Zeb2Tg/Tg NK cells (Fig. 2 A). Upon overnight culture 
with IL-15, Zeb2−/− NK cells also displayed decreased viabil-
ity compared with control NK cells (Fig. 2 B). This was not 
caused by an impaired expression of IL-15 receptor as CD122 
expression was in fact inversely correlated to the amount of 
Zeb2 expressed, whereas CD132 was normally expressed in 
the absence of Zeb2 (Fig. 2 C and not depicted). IL-15 signal-
ing was normal in CD11b− and DP NK cells as measured by 
early STAT5 and S6 phosphorylation (not depicted). However, 
Zeb2−/− CD27− NK cells responded poorly to IL-15, which 
could contribute to impair their viability (Fig.  2 D). Thus, 
Zeb2 is essential for the survival of mature NK cells.
Figure 1. Zeb2 is required for NK cell terminal maturation. (A) qPCR measurement of murine Zeb2 mRNA expression in sorted spleen WT NK cells 
of the indicated subsets and in T (CD3+) and B (CD19+) lymphocytes. n > 6 pooled from two independent experiments. (B and C) NK cells were purified 
from human PBMCs and further sorted by flow cytometry according to the gates shown in B. (C) RNA was then extracted and the level of T-bet, and Zeb2 
expression was measured by qPCR. n = 3 sorts (three different donors). (A–C) Bar graphs show the mean ± SD results. (D–J) Flow cytometry analysis on NK 
cells (CD3−CD122+NKp46+) isolated from the spleen and BM of Ncr1iCre/+ × Zeb2Tg/Tg (Tg/Tg), Ncr1iCre/+ × Zeb2Tg/+ (Tg/+), Ncr1iCre/+ × Zebfl/+ (+/−), Ncr1iCre/+ ×
Zeb2fl/fl (−/−), and littermate control (+/+) mice. (D) NK cell subsets were FACS sorted from the spleen of the indicated mice, and Zeb2 mRNA levels were
determined by qPCR. n ≥ 12 in each group pooled from two independent experiments. (E and F) Bar graphs showing NK cell percentages of viable CD45+
lymphocytes (E) and absolute NK cell numbers (F). (G–J) Analysis of NK cell maturation in the spleen or BM, as assessed by CD11b in combination with 
CD27 (G–I), KLRG1, or CD146 (J). Numbers on representative contour plots represent the percentage of cells per quadrant. Percentages (G, H, and J) and 
absolute cell numbers (I) of the indicated subsets among total NK cells are shown. All bar graphs show the mean ± SD results of ≥4 mice in each group
representative of at least two independent experiments. For statistics (Student’s t test), Tg mice were compared with littermate controls. *, P < 0.05; **, P < 
0.01; ***, P < 0.001; ****, P < 0.0001.
Second, we measured the mRNA expression of S1pr5, 
which controls the exit of NK cells from the BM. As shown 
in Fig. 2 E, Zeb2Tg/Tg NK cells expressed slightly higher levels 
of S1pr5 than control NK cells, whereas Zeb2−/− NK cells 
expressed S1pr5 mRNA at a lower level than control NK 
cells. This correlated with the lower responsiveness of Zeb2−/− 
NK cells to S1P in in vitro chemotaxis assays (Fig. 2 F) and 
with the lower frequency of sinusoidal NK cells in the BM of 
Ncr1iCre/+ × Zeb2fl/fl mice, irrespective of the NK cell subset 
analyzed (Fig. 2 G). Thus, increased apoptosis and decreased 
exit from the BM could contribute to the reduction in the 
number of mature NK cells observed in NK-Zeb2−/− mice.
NK-Zeb2−/− mice are highly susceptible to melanoma 
outgrowth, but Zeb2−/− NK cells have nearly normal 
cytotoxicity and cytokine secretion
As NK cells have been shown to be important in tumor 
immune surveillance, we compared the susceptibility of 
NK-Zeb2−/− and control animals to form B16F10 colony 
outgrowths after i.v. injection. We observed a marked increase 
in the number of melanoma nodules in the lungs and livers 
of NK-Zeb2−/− mice compared with WT littermate controls 
(Fig. 3 A). We sought to understand the cause of the increased 
susceptibility of NK-Zeb2−/− mice to melanomas, consider-
ing NK cell numbers, trafficking, and cytotoxicity/cytokine 
secretion as essential factors contributing to NK cell–mediated 
protection. NK-Zeb2−/− mice have only ∼15% of the nor-
mal number of NK cells in the lung, and they lack mature 
NK cells in this organ (Fig.  3 B). To investigate their traf-
ficking properties, we measured the expression of chemokine 
receptors. We observed a significant induction of expression 
of CXCR3, CXCR4, CCR2, and CCR5 in Zeb2−/− NK 
cells, especially in Zeb2−/− mature CD27− NK cells (Fig. 3 C 
and not depicted). Correlating with this, Zeb2−/− NK cells 
migrated better than control NK cells in response to gradients 
of chemokines that bind to these receptors (Fig. 3 D). Next, 
we isolated lung mononuclear cells at different time points 
after B16 injection and followed NK cell degranulation and 
Figure 2. Zeb2 is indispensable for survival of 
mature NK cells and for their exit from the BM. 
(A) Flow cytometry measurement of live/dead staining 
and Annexin V binding on splenic NK cells. Bar graphs 
represent the mean percentage viable (live/death−An-
nexin V−) ± SD results of at least three mice in each 
group representative for at least two independent 
experiments. (B) Spleen cells from WT and NK-Zeb2−/− 
mice were cultured overnight in the presence of IL-
15. NK cell viability was then measured as in A. n =
5 representative of three independent experiments. 
(C) Flow cytometry measurement of CD122 expres-
sion levels as mean fluorescent intensity (MFI). The 
bar graph shows the mean ± SD results of at least 
four mice in each group representative of at least 
two independent experiments. (D) Flow cytometry 
analysis of STAT5 and S6 phosphorylation in gated 
splenic CD27− NK cells of the indicated mice, after in 
vitro stimulation with IL-15 for 1 h. Results show the 
mean ± SD. n = 5 representative of two independent 
experiments. (E) qPCR measurement of S1pr5 mRNA 
expression in NK cell subsets sorted from the spleen 
of mice of the indicated genotype. n > 11 pooled from 
two independent experiments. (F) Chemotaxis assay of 
spleen NK cell subsets of the indicated genotype using 
S1P. n = 4 pooled from two independent experiments. 
(G) Frequency of sinusoidal NK cells of each subset 
in the BM of the indicated mice. Mice were injected 
with anti-CD45 i.v. and subsequently sacrificed 1 min 
later, leading to CD45 labeling of sinusoidal cells. Bar 
graphs show the mean ± SD results of four mice in 
each group representative of at least two indepen-
dent experiments. For statistics, Tg mice were com-
pared with littermate controls. *, P < 0.05; **, P < 0.01; 
***, P < 0.001; ****, P < 0.001 (Student’s t test).
IFN-γ secretion after in vitro stimulation with different stim-
uli. The IFN-γ production and degranulation of Zeb2−/− NK
cells was normal or even increased at all time points analyzed 
and for all subsets (Figs. 3 E and not depicted). Trail and FasL 
expression were also normal on Zeb2−/− NK cells (not de-
picted). Altogether, our data show no impairment of NK cell 
effector functions and responsiveness to chemokines in NK-
Zeb2−/− mice, suggesting that their higher susceptibility to 
B16F10 melanoma cells is mostly caused by a low number of 
NK cells in the periphery.
Tbx21−/− and Zeb2−/− mature NK cells are 
phenotypically very similar
Several traits of Zeb2 mutant NK cells were reminiscent of the 
phenotype of Tbx21−/− (T-bet KO) NK cells. For example, 
Tbx21−/− mice lack mature CD27− NK cells (Soderquest et al., 
2011), their peripheral NK cells display high rates of apoptosis 
(Townsend et al., 2004), and they have an impaired capacity to 
exit BM as a result of decreased expression of S1PR5 (Jenne 
et al., 2009). These observations prompted us to compare the 
phenotype of NK cells mutant for either TF in more details. 
The percentage and number of spleen NK cells as well as 
the maturation status were very similar in Tbx21−/− and NK-
Zeb2−/− mice (Fig. 4, A–C). Combined deficiency of T-bet and 
Zeb2 (double KO [DKO]) in NK cells did not impair further 
NK cell maturation but significantly reduced the percentage 
and number of NK cells compared with deficiency in either TF 
alone (Fig. 4, A–C). We performed a flow cytometry analysis of 
40 cell surface and intracellular proteins and compared subset 
by subset NK cells of the three genotypes. Fig. 4 D presents 
the results of the FACS analysis under the form of a global hi-
erarchical clustering of samples and an expression heat map of 
markers for the three NK cell subsets. For CD11b− and DP NK 
cells, WT and Zeb2−/− NK cells clustered apart from DKO and 
Tbx21−/− NK cells. This was the result of a large group of pro-
teins that were either up- or down-regulated in Tbx21−/− and 
DKO NK cells but not changed in Zeb2−/− NK cells compared 
with WT NK cells (blue stars; “T-bet–dependent genes”). For 
CD27− NK cells that express the highest level of Zeb2, Zeb2−/−, 
DKO, and Tbx21−/− NK cells clustered together, apart from 
WT NK cells. This effect was the result of a large group of pro-
teins that were coregulated in Zeb2−/−, Tbx21−/−, and DKO 
NK cells, either up or down-regulated compared with WT NK 
cells (red squares; “Zeb2/T-bet–dependent genes”).
Figure 3. NK-Zeb2−/− mice are highly susceptible to B16F10 melanomas. (A) NK-Zeb2−/− and littermate control (NK-Zeb2+/+) mice were i.v. injected 
with 200,000 B16F10 melanoma cells. Mice were sacrificed 12 d later, and tumor nodules in lung and liver were counted. n = 6 representative for two inde-
pendent experiments. (B) Absolute lung NK cell numbers of unchallenged NK-Zeb2−/− and littermate control (+/+) mice. FACS plots show a representative 
CD11b/CD27 profile of gated CD3−CD122+NK1.1+ NK cells as determined by flow cytometry. n ≥ 3 representative for two independent experiments. (C) Flow 
cytometry measurement of the expression of CXCR3 and CCR2 by gated splenic NK cell (CD3−CD122+NKp46+) subsets. Results show the percentage ± SD 
of positive cells among NK cells of the indicated subset. n > 5 representative of at least two independent experiments. (D) Chemotaxis assay of spleen NK 
cells of the indicated genotype using CXCL10 and CCL2. n = 4–8 pooled from two independent experiments. (E) Lung lymphocytes were isolated from day 
1 B16-bearing animals and restimulated ex vivo for 4 h in the indicated conditions in the presence of GolgiStop. Their production of IFN-γ was measured
using flow cytometry. n = 4 in each group, representative for two independent experiments. All bar graphs represent the mean ± SD results. *, P < 0.05; 
**, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (Student’s t test).
Thus, several points can be concluded from the analysis 
in Fig. 4 D: (a) T-bet is already active in immature NK cells, 
whereas Zeb2 only has limited action in this subset (blue stars); 
(b) when both TFs are coexpressed at high levels, they have 
coordinated activities on the expression of many genes (red 
squares); (c) there is little impact of a combined deficiency 
compared with lack of T-bet only; (d) several proteins such 
as CD39, CD146, or CD127 are already regulated by T-bet 
in immature NK cells and are coregulated by T-bet and Zeb2 
in mature NK cells, thus showing that once induced, Zeb2 
helps regulate T-bet target genes; and (e) a few genes were 
also dependent only on Zeb2, especially in DP and CD27− 
(green circles; “Zeb2-dependent genes”), showing that Zeb2 
may have occasional T-bet–independent activity.
T-bet is necessary to induce Zeb2 expression
Given the earlier action of T-bet on gene expression in NK 
cells, we hypothesized that Zeb2 was acting downstream 
of T-bet. To test this point, we measured Zeb2 mRNA ex-
pression in NK cells expressing graded doses of T-bet. NK 
cell subsets were sorted from Tbx21−/−, Tbx21+/−, and WT 
mice. The level of T-bet in NK cell subsets from these mice is 
Figure 4. T-bet and Zeb2 KO NK cells are near phenocopies. (A–C) Percentage of live lymphocytes (A) and absolute numbers (B) of NK cells in the 
spleen and their maturation status as assessed by CD11b/CD27 staining, shown as a percentage among NK cells (C). n = 4–5 in each group, pooled from 
two independent experiments. All bar graphs represent the mean ± SD results. **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. (D) Flow cytometry analysis of 
the expression of the indicated genes by gated splenic NK cell subsets isolated from Ncr1iCre/+ × Zeb2fl/fl (Zeb2−/−), Tbx21−/−, NK-Zeb2−/− × Tbx21−/− (DKO), 
and littermate control (+/+, WT) mice. n = 4–5 in each group. (top) Hierarchical clustering of the indicated samples according to the Euclidean distance 
calculated on the basis of the MFI of all stainings for CD11b−, DP, and CD27− NK cells. (bottom) MFI of the staining for all markers analyzed, presented as 
a heat map, after log2 transformation and row-wise centering of the data. Blue stars correspond to genes whose expression is regulated by T-bet and not 
Zeb2, i.e., significantly different (P < 0.1) between WT and T-bet KO NK cells but not between WT and Zeb2 KO NK cells. Red squares correspond to genes 
coregulated by T-bet and Zeb2, i.e., genes whose expression is significantly different between WT and T-bet KO and Zeb2 KO NK cells and similar between 
T-bet KO and Zeb2 KO. Green circles correspond to genes regulated by Zeb2, i.e., genes whose expression is significantly different between WT and Zeb2 
KO but not between WT and T-bet KO NK cells.
shown in Fig. 5 A. The steady-state level of Zeb2 transcripts 
was significantly decreased in Tbx21+/− and even further in 
Tbx21−/− NK cells compared with controls, showing that 
T-bet is necessary for optimal Zeb2 expression in NK cells. 
We also compared the level of T-bet and Zeb2 mRNA in WT 
versus T-bet Tg mice (T-bet Tg). The latter mice express T-bet 
under the control of the Cd2 promoter, which is highly active 
in T cells (Ishizaki et al., 2007). The results in Fig. 5 B show 
that T-bet expression induced high levels of Zeb2 mRNA 
in both CD4 and CD8 T cells, irrespective of the subset an-
alyzed (based on CD44/CD62L expression). Thus, T-bet is 
necessary for optimal expression of Zeb2 in NK cells.
Restoration of Zeb2 levels in Tbx21−/− NK cells partially 
reinstate a wild-type phenotype and antitumor function
Our results raised the possibility that the lack of Zeb2 in-
duction in Tbx21−/− NK cells contributed in a major way to 
the observed NK cell phenotype. To test this hypothesis, we 
restored Zeb2 levels in NK cells in Tbx21−/− mice by cross-
ing R26-Zeb2Tg mice with Ncr1iCre and Tbx21−/− mice. 
We verified that the Zeb2 transgene restored a physiological 
level of Zeb2 in the different NK cell subsets (Fig. 6 A) and 
analyzed the phenotype of NK cells in the different mouse 
strains generated. Expression of Tg Zeb2 restored a wild-
type phenotype when considering the following parame-
ters: maturation as assessed by CD11b/KLRG1 (Fig. 6 C) 
and expression of CD122, CXCR3, CCR2, and CD127 
(Fig.  6  D and not depicted). However, the reexpression 
of Zeb2 incompletely restored the percentage of periph-
eral NK cells (Fig. 6 B), NK cell maturation as assessed by 
CD27/CD11b (Fig. 6 C), and CD146 and S1PR5 expres-
sion (Fig. 6 E). The latter observations suggest an essential 
role of T-bet in repressing CD27 expression and inducing 
high levels of S1PR5 necessary for NK cell exit from the 
BM to the blood. To test whether the Zeb2 transgene could 
restore NK cell function, we also compared the susceptibil-
ity of the various mouse strains to form B16F10 nodules. 
The results shown in Fig. 6 F confirm previous observations 
that Tbx21−/− mice fail to control B16F10 metastasis (Wer-
neck et al., 2008). However, Tg expression of Zeb2 in NK 
cells fully restored their capacity to control the tumor.
Altogether, these results indicate that the lack of Zeb2 ex-
pression contributes in a major way to the overall phenotype of 
Tbx21−/− NK cells. However, T-bet also has Zeb2-independent 
roles in NK cell maturation and homeostasis, further establishing 
the synergy between these factors during NK cell differentiation.
Concluding remarks
Here, we demonstrate, using an unprecedented panel of 
mouse models with different Zeb2 allele numbers, that Zeb2 
is an essential regulator of the NK cell terminal differentiation 
program. ZEB2 is also up-regulated during differentiation of 
human NK cells, suggesting that Zeb2 regulates NK cell dif-
ferentiation across mammals. Zeb2 not only promotes NK 
cell terminal differentiation, but also preserves viability of ma-
ture NK cells and induces their exit from the BM, all factors 
contributing to maintain the pool of peripheral mature NK 
cells, essential for efficient antitumor function in peripheral 
sites such as the lung.
Our data show that Zeb2 controls NK cell matura-
tion downstream of T-bet. In immature NK cells, T-bet is 
already active, and Tbx21 deficiency leads to the deregulation 
of several genes in this subset. When T-bet levels increase, 
Zeb2 expression is induced in a T-bet–dependent manner, 
and T-bet and Zeb2 then control the expression of the same 
genes. This suggests the existence of a feed-forward loop 
whereby late induction of Zeb2 would help reinforce T-bet 
action. Such a loop may serve to irreversibly induce termi-
nal NK cell maturation. Another supporting evidence of this 
model comes from in silico analyses by the ImmGen consor-
tium and the Ontogenet algorithm, which predict T-bet and 
Zeb2 to coregulate many target genes in NK cells includ-
ing Klrg1, Mcam (CD146), and S1pr5 (Jojic et al., 2013). In 
general, feed-forward regulatory loops occur very frequently 
Figure 5. T-bet is necessary and sufficient to induce Zeb2 expression. (A) Flow cytometry (left) or qPCR analysis (right) of Tbx21 protein or Zeb2 RNA 
levels in NK cell subsets from spleen suspensions of the indicated mouse strains. n = 3–7 mice in each group representative for two independent experi-
ments. (B) CD4 and CD8 T cells subsets as indicated were FACS sorted from the spleen of CD2–T-bet–Tg and littermate control mice, and their expression of 
T-bet and Zeb2 were measured by qPCR. n = 3 in each group, two independent experiments. All bar graphs represent the mean ± SD results. *, P < 0.05; 
**, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (Student’s t test).
in transcriptional networks (Gerstein et al., 2012). They are 
believed to buffer variations in input stimuli and increase 
robustness of regulatory circuits. The T-bet → Zeb2 loop ap-
pears to regulate important aspects of NK cell differentiation 
such as trafficking and responsiveness to chemokines, pro-
liferation, and survival.
Tg expression of Zeb2 in the absence of Tbx21 partially 
restored a wild-type NK cell phenotype. This suggests that for 
many genes and in mature NK cells, Zeb2 and not T-bet is 
important to control expression of target genes. Yet, the very 
same genes are dependent on T-bet in immature NK cells, at 
a stage where Zeb2 is expressed at low and ineffective lev-
els. This suggests that both TFs contribute to transcriptional 
activation in a cumulative rather than synergistic fashion, 
a notion arising from the analysis of genome-wide studies 
(Spivakov, 2014). Other TFs may also cooperate with T-bet 
and Zeb2 to confer robustness to the regulatory network as 
Zeb2 is known to recruit several transcriptional cofactors 
(Conidi et al., 2011). The identification of these transcrip-
tional complexes and of their precise actions will be goals 
of future studies to better understand the interplay of TF 
during NK cell maturation.
Figure 6. Tg Zeb2 expression rescues the matu-
ration defect of Tbx21−/− NK cells. Flow cytome-
try and qPCR measurement on electronically gated or 
sorted NK cell (CD3−CD122+NKp46+) subsets isolated 
from spleens of Ncr1iCre/+ × Zeb2Tg/Tg (NK-Zeb2Tg/Tg), 
Tbx21−/−, Ncr1iCre/+ × Zeb2Tg/Tg × Tbx21−/− (T-bet−/− × 
NK-Zeb2TgTg), and littermate controls. n ≥ 3. (A) Zeb2 
expression levels as determined by qPCR. (B) NK cell 
percentages of viable lymphocytes. (C, left) Represen-
tative FACS plots showing CD11b expression in com-
bination with CD27 and KLRG1. Numbers represent 
percentage of cells per quadrant. (C, right) Bar graphs 
show percentage of the indicated subset among total 
NK cells. (D) Results show MFI of CD122, CCR2, and 
CD127. (E) qPCR measurement of S1PR5 on sorted 
NK cell subsets and MFI of CD146 on gated NK cells. 
(F) The indicated mice were i.v. injected with B16-F10 
melanoma cells. Mice were sacrificed at day 12, and 
tumor nodules in lung were counted. All bar graphs 
represent the mean ± SD results. For statistics (Stu-
dent’s t test), Tg mice were compared with littermate 
controls, and Tbx21−/− × NK-Zeb2Tg/Tg were compared 
with Tbx21−/− and littermate controls as indicated. 
*, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.
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Mice. This study was performed in strict accordance with the 
French and Belgian recommendations for the ethical evalua-
tion of experiments using laboratory animals and the European 
guidelines 86/609/CEE or the guidelines for animal care at the 
VIB site Ghent. C57BL/6 mice were purchased from Charles 
River (L’Arbresle). Ncr1iCre mice were crossed with Zeb2fl/fl 
mice or R26-Zeb2Tg mice. All strains including Tbx21−/− and 
CD2–T-bet Tg mice were bred in our animal house. Litters 
with mice from 8 to 24 wk old were used for analysis.
Blood collection from healthy human subjects. Human pe-
ripheral blood was drawn from healthy volunteers, and in-
formed consent was obtained from all participants. PBMCs 
were then isolated by Ficoll gradient centrifugation, and NK 
cells were isolated and further sorted as described in Fig. 1 B.
Flow cytometry. Single-cell suspensions of mouse BM, spleen, 
and lungs were obtained and stained. Human whole blood 
samples from healthy donors were collected by venous punc-
ture in heparin-containing vials. PBMCs were isolated by Fi-
coll gradient centrifugation. Intracellular stainings for TFs or 
granzyme A and granzyme B were performed using Foxp3 
kit (eBioscience). Cell viability was measured using Annexin 
V (BD)/live-dead fixable (eBioscience) staining. Lyse/Fix and 
PermIII buffers (BD) were used for intracellular staining of 
phosphorylated proteins. Flow cytometry was performed on 
a FAC SCanto, a FACS LSR II, a FACS Fortessa (all BD), a 
Navios (Beckman Coulter), or a MACSquant (Miltenyi Bio-
tec). Data were analyzed using FlowJo (Tree Star). Clustering 
analyses of flow cytometry data and creation of heat maps 
were performed using the R software. Antibodies were pur-
chased from eBioscience, BD, R&D Systems, Beckman 
Coulter, or BioLegend. We used mouse antibodies against 
Blimp1 (5E7), BTLA (8F4), CCR2 (475301), CCR5 (HM-
CCR5), CD107a (1D4B), CD11a (M17/4), CD11b (M1/70), 
CD11c (N418), CD122 (5H4), CD127 (17R34), CD132 
(TUGm2), CD146 (ME-9F1), CD16/32 (2.4G2), CD160 
(CNX46.3), CD18 (M18/2), CD19 (ebio1D3), CD212 
(114), CD218 (P3TUN YA), CD223 (ebioC9B7W), CD226 
(10E5), CD24 (M1/69), CD244 (ebio244f4), CD25 (PC61), 
CD27 (LG.7F9), CD29 (9E67), CD3 (145-2C11), CD39 
(24DMS1), CD43 (1B11), CD44 (1M7), CD45 (30F11), 
CD48 (HM48.1), CD49a (Ha31/8), CD49b (DX5), CD49d 
(R1.2), CD49e (ebioHma5.1), CD49f (ebioGoH3), CD51 
(RMV.7), CD62L (Mel14), CD69 (H1.2F3), CD71 (R17217), 
CD94 (18D3), CD95 (15A7), CD98 (RL398), CXCR3 
(CXCR3-173), CXCR4 (2B11), E4BP4 (52M-E19), Eomes 
(Dan11mag), GzmA (3G8.5), GzmB (NGZB), IA-IE 
(M5/114), IFN-γ (XMG1), Ki67 (B56), KLRG1 (2F1),
Ly49a (YE1.48.10.6), Ly49D (4E5), Ly49F (HBF719), 
Ly49G2 (4D11), Ly49H (3D10), Ly6C (AL21), NKG2ACE 
(20D5), NKG2D (CX5), NKp46 (29A1.4), pS6 (N7.548), 
pSTAT5 (47/stat5), perforin (ebio-OMA KD), T-bet 
(ebio4B10), and Trail (N2B2). We used human antibodies 
against CD3 (UCHT1), CD14 (RMO52), CD19 (HD237), 
CD56 (HLDA6), CD57 (NC1), NKG2A (Z199), KIR3DL1 
(DX9), and KIR2DL1 (HP-MA4). In all panels, a minimum 
of 50 cells per NK cell subset was analyzed.
Cell sorting and RNA preparation. Lymphocytes were ob-
tained from spleen, and NK cells were enriched using NK 
cell isolation kit II for mouse (Miltenyi Biotec) or by first 
incubating for 20 min at 4°C with a cocktail of biotinylated 
mAbs: rat anti–mouse CD3 (2C11), CD5 (53-7.3), CD19 
(ebio1D3), CD24 (M1/69), F4/80 (BM8), TER-119 
(ter119), GR1(RB6.8) (eBioscience). After incubation with 
anti-biotin microbeads (Miltenyi Biotec), NK cells were en-
riched using magnetic separation. Enriched NK cells were 
then stained with a life/death marker in combination with 
anti-CD27, anti-CD11b, anti-CD3, anti-CD19, anti-TCRb, 
streptavidin, and anti-NK1.1 or anti-NKp46 and anti-CD122 
and subsequently sorted into different subsets using a FAC 
SAria Cell Sorter (BD). In some experiments, CD4 and 
CD8 T cells were sorted using anti-CD3, anti-CD4, an-
ti-CD8, anti-CD44, and anti-CD62L antibodies. Purity of 
sorted cell populations was >98%, as checked by flow cy-
tometry. Sorted cells were lysed using TRIzol reagent (Invi-
trogen) or RLT buffer from the RNeasy Micro kit (QIA 
GEN), and RNA was extracted according to the manu-
facturer’s instructions.
Quantitative RT-PCR. We used the High-Capacity RNA-
to-cDNA kit (Applied Biosystems) or iScript cDNA syn-
thesis kit (Bio-Rad Laboratories) to generate cDNA for 
RT-PCR. PCR was performed with a Sybr Green–based 
kit (FastStart Universal SYBR Green Master; Roche) or 
SensiFast SYBR No-ROX kit (Bioline) on a StepOne plus 
instrument (Applied Biosystems) or a LightCycler 480 sys-
tem (Roche). Primers were designed using the Roche 
software. We used the following primers for mouse qPCR: 
Zeb2 F, 5′-CCA GAGGA AACAA GGATT TCAG-3′; Zeb2
R, 5′-AGG CCTGA CATGT AGTCT TGTG-3′; S1pr5 F,
5′-GCC TGGTG CCTAC TGCTA CAG-3′; S1pr5 R, 5′-
CCT CCGTC GCTGG CTATT TCC-3′; Tbx21 F, 5′-CAA
CCAGC ACCAG ACAGA GA-3′; Tbx21 R, 5′-ACA AACAT 
CCTGT AATGG CTTG-3′; Gapdh F, 5′-GCA TGGCC 
TTCCG TGTTC-3′; and Gapdh R, 5′-TGT CATCA 
TACTT GGCAG GTTTCT-3′. The following primers were
used for human qPCR: T-bet F, 5′-AGG ATTCC GGGAG 
AACTT TG-3′; Tbet R, 5′-CCC AAGGA ATTGA CAGTT 
GG-3′; Zeb2 F, 5′-AGG AGCTG TCTCG CCTTG-3′; 
Zeb2 R, 5′-GGC AAAAG CATCT GGAGT TC-3′; OAZ1
F, 5′-GGA TAAAC CCAGC GCCAC-3′; and OAZ1 R, 5′-
TAC AGCAG TGGAG GGAGA CC-3′.
Chemotaxis assays. Spleen cells were suspended in RPMI 
1640 supplemented with 4 mg/ml fatty acid–free bovine al-
bumin (Sigma-Aldrich). The same medium was used to pre-
pare S1P (Sigma-Aldrich) at 10−8 M or chemokines at 50 ng/ml 
(R&D Systems). Cell migration was analyzed in Transwell 
chambers (Costar) with 5-µm-pore-width polycarbonate fil-
ters. Transmigrated cells were stained for CD3, NK1.1, CD27, 
and CD11b and counted by flow cytometry.
Cell culture and stimulation. Lung or spleen single-cell sus-
pensions were prepared and cultured in the presence of Gol-
giStop (BD) without or with cytokines (25 ng/ml rmIL-12 
and 20 ng/ml rmIL-12 from R&D Systems) or on anti-
body-coated plates (anti-Ly49D at 10 µg/ml) or with B16F10 
or YAC1 cell lines (400,000 cells/well) for 4 h at 37°C. Sur-
face and intracellular stainings were then performed, and 
IFN-γ production was measured by flow cytometry. For
phospho flow analyses, spleen cells were stimulated for 1 h in 
the presence of graded doses of rmIL-15 (R&D Systems) at 
37°C. Spleen cell suspensions were also incubated for 24 h at 
37°C with graded doses of rmIL-15 from R&D Systems, and 
NK cell survival was assessed using Annexin V/live-dead staining.
In vivo labeling of sinusoidal lymphocytes. Mice were in-
jected i.v. with 1 µg anti-CD45 mAb coupled to phycoeryth-
rin (BD). Mice were sacrificed 1 min after antibody injection, 
and their BM was collected.
Tumor model. B16F10 melanoma cells were resuspended in 
1× HBSS and injected into the tail veins of the mice (2 × 105 
cells/mouse). The numbers of lung and liver surface nodules 
were counted under a dissecting microscope 12 d after injec-
tion. In some experiments, lungs were collected, and lung 
mononuclear cells were purified after DNase I/Collagenase A 
digestion 1 d after B16 injection, divided over 5 wells with 
different conditions, and NK cell functions were then assayed 
using a 4-h ex vivo culture as described in “Cell 
culture and stimulation.”
Statistical analyses. Error bars represent the standard devia-
tion. Statistical analyses were performed using two-tailed Stu-
dent’s t tests or nonparametric tests when appropriate. These 
tests were run on the Prism software (GraphPad Software). 
Levels of significance are expressed as p-values (*, P < 0.05; 
**, P < 0.01; ***, P < 0.001; ****, P < 0.0001).
Online supplemental material. Fig. S1 contains valuable data 
that further clarify the manuscript and the different mouse lines 
used in this study. Online supplemental material is available at 
http ://www .jem .org /cgi /content /full /jem .20150809 /DC1.
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